Arena Pharma
Stock
Stock
ISIN: US0400476075
Ticker: ARNAn
US0400476075
ARNAn
Price
Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Arena Pharma?
Arena Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$10.13. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Arena Pharma's stock?
Currently, 1 analysts cover Arena Pharma's stock, with a consensus target price of $100.00. Analyst ratings provide insights into the stock's expected performance.
What is Arena Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, Arena Pharma reported a revenue of $54.00K.
What is the EBITDA for Arena Pharma?
Arena Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$541.79M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Arena Pharma?
Arena Pharma has a free cash flow of -$453.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Arena Pharma have, and what sector and industry does it belong to?
Arena Pharma employs approximately 448 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
Financials
- EPS (TTM)
- -$10.13
- Revenue (TTM)
- $54.00K
- EBITDA (TTM)
- -$541.79M
- Free Cashflow (TTM)
- -$453.00M
Analyst Ratings
The price target is $100.00 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT.
- Employees
- 448
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US0400476075
- Primary Ticker
- ARNAn